Chardan Capital Maintains Buy on EyePoint, Raises Price Target to $65
Benzinga Newsdesk 4 months ago
NewsPrice TargetAnalyst Ratings
Chardan Capital analyst Andreas Argyrides maintains EyePoint (NASDAQ:EYPT) with a Buy and raises the price target from $29 to $65.
Chardan Capital analyst Andreas Argyrides maintains EyePoint (NASDAQ:EYPT) with a Buy and raises the price target from $29 to $65.